Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Planned share buyback to service the employees share subsidy program
Press release

Planned share buyback to service the employees share subsidy program

Published on August 3, 2018
  • High acceptance volume of approx. 50 percent globally
  • Transfer of shares in the amount of EUR 46 million to employees

As outlined in the IPO prospectus dated March 5, 2018, the participating entities within Siemens Healthineers offered a one-time share subsidy program in the context of the IPO to their eligible employees based on which the employees will receive bonus shares in addition to their own investment in shares. By the end of the offer period on July 6, 2018, the acceptance volume was excellent – globally it corresponded to approx. 50 percent of the maximum volume that could be ordered, in Germany even approx. 70 percent. “The high level of participation in our first employee share program shows just how convinced our colleagues are of the positive future of our company,” said Bernd Montag, CEO Siemens Healthineers.

In total, shares in the amount of EUR 46 million (including share bonus) will be transferred to employees. The respective share buyback to be announced shortly will be performed in the amount of up to EUR 55 million in particular in order to allow the compensation of potential share price fluctuations between share prices on the share buyback days and the reference date based on which shares have to be delivered.

Download this press release(pdf, 223.09 KB)
Reference Number: PR-20180802024SHS

This document contains statements related to our future business and financial performance and future events or developments involving Siemens Healthineers that may constitute forward-looking statements. These statements may be identified by words such as “expect”, “look forward to”, “anticipate”, “intend”, “plan”, “believe”, “seek”, “estimate”, “will”, “project” or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to shareholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements are based on the current expectations and certain assumptions of Siemens Healthineers' management, of which many are beyond Siemens Healthineers’ control. These are subject to a number of risks, uncertainties and factors, including, but not limited to those described in disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Siemens Healthineers may (negatively or positively) vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Siemens Healthineers neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This document includes – in IFRS not clearly defined – supplemental financial measures that are or may be non-GAAP financial measures. These supplemental financial measures should not be viewed in isolation or as alternatives to measures of Siemens Healthineers' net assets and financial positions or results of operations as presented in accordance with IFRS in its Consolidated Financial Statements. Other companies that report or describe similarly titled financial measures may calculate them differently.

Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

Siemens Healthineers 2017

Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to achieve better outcomes at lower costs by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.8 billion and profit of €2.5 billion and has about 48,000 employees worldwide.